Tirzepatide/GLP-1 (15MG)
Tirzepatide / GLP-1 (15MG)
Tirzepatide is a dual GIP and GLP-1 receptor agonist developed for advanced metabolic and endocrinology research. This 15MG formulation is produced for laboratory and investigational use, offering high purity and consistency for controlled research environments.
Tirzepatide’s dual-incretin mechanism has made it a significant compound of interest in studies involving glucose regulation, metabolic pathways, and receptor signaling activity.
Product Details:• Compound: Tirzepatide (Dual GIP/GLP-1 receptor agonist)• Strength: 15MG per vial• High purity, research-grade quality• Lyophilized powder for enhanced stability• Securely sealed and clearly labeled
Intended Use:For laboratory research and clinical investigation purposes only. Not for human consumption.
Proper cold storage is recommended to maintain compound integrity.
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
FDA Disclaimer: Information and products on this website have not been assessed by the FDA and are not proposed for diagnosing, treating, curing, or preventing any health condition
Key Information: Peptides are not recognized as dietary supplements. Research chemicals are defined as substances used by researchers for medical and scientific study. These chemicals are meant for laboratory research use only and are not for human or veterinary application. This clear distinction is indicated on the labels of research chemicals, exempting them from specific regulations under Title 21, Parts 100-740 of the Code of Federal Regulations (21CFR).
){kind=link}